Carmell Therapeutics Stock Price on September 13, 2024
| CTCXW Stock | 0.06 0 1.96% |
If you're considering investing in Carmell Stock, it is important to understand the factors that can impact its price. As of today, the current price of Carmell Therapeutics stands at 0.06, as last reported on the 29th of November, with the highest price reaching 0.06 and the lowest price hitting 0.06 during the day. Carmell Therapeutics is out of control given 3 months investment horizon. Carmell Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0565, which signifies that the company had a 0.0565% return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.69% are justified by taking the suggested risk. Use Carmell Therapeutics Downside Deviation of 18.09, mean deviation of 12.44, and Risk Adjusted Performance of 0.0129 to evaluate company specific risk that cannot be diversified away.
At this time, Carmell Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to climb to about 13.5 M in 2024, whereas Common Stock is likely to drop 2,194 in 2024. . At this time, Carmell Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to climb to 1.78 in 2024, whereas Price Earnings To Growth Ratio is likely to drop (0.01) in 2024. Carmell Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Carmell |
Sharpe Ratio = 0.0565
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | CTCXW | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 29.89 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.69 actual daily | 33 67% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Carmell Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Carmell Therapeutics by adding it to a well-diversified portfolio.
Shares Short Prior Month 7.5 K | Shares Short 10.6 K |
Related Headline
Unicycive Therapeutics Headline on 13th of September 2024
Disposition of tradable shares by Jermasek Douglas of Unicyc... by Jermasek Douglas
Filed transaction by Unicycive Therapeutics Officer Evp Of Corporate Strategy. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Carmell Therapeutics Valuation on September 13, 2024
It is possible to determine the worth of Carmell Therapeutics on a given historical date. On September 13, 2024 Carmell was worth 0.07 at the beginning of the trading date compared to the closed value of 0.06. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Carmell Therapeutics stock. Still, in general, we apply an absolute valuation method to find Carmell Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Carmell Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Carmell Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.07 | 0.07 | 0.07 | 0.07 | 54,047 | |
09/13/2024 | 0.07 | 0.07 | 0.05 | 0.06 | 12,521 |
| 0.10 | 0.10 | 0.05 | 0.10 | 11,987 |
| Backtest Carmell Therapeutics | | | Carmell Therapeutics History | | | Carmell Therapeutics Valuation | Previous | Next |
Carmell Therapeutics Trading Date Momentum on September 13, 2024
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Carmell Therapeutics Fundamentals Correlations and Trends
By evaluating Carmell Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Carmell Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Carmell financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Carmell Therapeutics Stock history
Carmell Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Carmell is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Carmell Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Carmell Therapeutics stock prices may prove useful in developing a viable investing in Carmell Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 11 M | 13.5 M |
Carmell Therapeutics Stock Technical Analysis
Carmell Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Carmell Therapeutics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Carmell Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Carmell Therapeutics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Carmell Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Carmell Therapeutics shares will generate the highest return on investment. By undertsting and applying Carmell Therapeutics stock market strength indicators, traders can identify Carmell Therapeutics entry and exit signals to maximize returns
Carmell Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Carmell Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Carmell Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Carmell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0129 | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (2.81) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0369 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Carmell Stock Analysis
When running Carmell Therapeutics' price analysis, check to measure Carmell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carmell Therapeutics is operating at the current time. Most of Carmell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Carmell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carmell Therapeutics' price. Additionally, you may evaluate how the addition of Carmell Therapeutics to your portfolios can decrease your overall portfolio volatility.